Clinical Trial Update: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis

View source ↗

Summary

An observational study evaluating the safety and efficacy of Remsima (infliximab biosimilar) in patients with Ankylosing Spondylitis was terminated, and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remsima (infliximab)

Snippet

Sponsor: Celltrion | Conditions: Ankylosing Spondylitis | Status: TERMINATED | Results posted: 2024-12-09